US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Metagenomi Technologies, LLC

1.23

+0.03002.50%

Volume:303.20K

Turnover:375.11K

Market Cap:46.47M

PE:-0.49

High:1.26

Open:1.22

Low:1.20

Close:1.20

52wk High:3.95

52wk Low:1.13

Shares:37.78M

Float Shares:25.57M

Volume Ratio:2.43

T/O Rate:1.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4900

EPS(LYR):-2.3634

ROE:-60.61%

ROA:-28.19%

PB:0.41

PE(LYR):-0.52

Loading ...

Overview Company News Filings

Metagenomi Q1 FY26 net loss narrows to $23.06 million; revenue drops to $1.25 million

Metagenomi Therapeutics Inc - Q1 Net Loss per Share $0.61

THOMSON REUTERS

Press Release: Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Metagenomi Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Metagenomi Therapeutics announces annual shareholder meeting

MGX Resources Reports Lower March Quarter Iron Ore Sales; Shares Rise 3%

MT Newswires Live

Macmahon Named Preferred Contractor for $38m Groundrush Decline

Macmahon Named Preferred Contractor for $38m Groundrush Underground Project

Metagenomi reports compact CRISPR nuclease MG119-28 shows higher genome-editing efficiency

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

MGX Resources to Relocate Registered Office in West Perth

OpenAI Nearing $10 Billion Funding Round from MGX, Coatue, and Thrive Capital

Mangoceuticals announces patent filing for MGX-0024

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Chardan Capital Remains a Buy on Metagenomi, Inc. (MGX)

Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate

Benzinga Earnings

Metagenomi Therapeutics posts FY 2025 collaboration revenue of USD 25.2 million (-51.8%)

Press Release: Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MGX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MGX\",,,,,undefined,":{"symbol":"MGX","market":"US","secType":"STK","nameCN":"Metagenomi Technologies, LLC","latestPrice":1.23,"timestamp":1787342400000,"preClose":1.2,"halted":0,"volume":303195,"delay":0,"changeRate":0.025000000000000022,"floatShares":25568300,"shares":37777105,"eps":-2.49,"marketStatus":"Pre-Mkt","change":0.03,"latestTime":"08-24 06:35:58 EDT","open":1.22,"high":1.26,"low":1.2,"amount":375114.6428505,"amplitude":0.05,"askPrice":1.58,"askSize":100,"bidPrice":1.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.49,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.23,"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.23,"latestTime":"19:30 EDT","volume":312,"amount":374.6677,"timestamp":1787355006937,"change":-0.03,"changeRate":-0.02439,"amplitude":0.02439},"volumeRatio":2.427229931862981},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MGX\",,,,,undefined,":{"symbol":"MGX","floatShares":25568300,"roa":"-28.19%","roe":"-60.61%","lyrEps":-2.363396,"volumeRatio":2.427229931862981,"shares":37777105,"dividePrice":0,"high":1.26,"amplitude":0.05,"preClose":1.2,"low":1.2,"week52Low":1.13,"pbRate":"0.41","psRate":"3.43","week52High":3.95,"institutionHeld":0,"latestPrice":1.23,"eps":-2.49,"divideRate":0,"volume":303195,"delay":0,"ttmEps":-2.49,"open":1.22,"prevYearClose":1.62,"prevWeekClose":1.23,"prevMonthClose":1.19,"prevQuarterClose":1.19,"fiveDayClose":1.23,"twentyDayClose":1.205,"sixtyDayClose":1.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"MGX","fiscalQuarterEnding":"2026/06","expectedEps":-0.63,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.73},{"market":"US","date":"2026-05-11","symbol":"MGX","fiscalQuarterEnding":"2026/03","expectedEps":-0.6,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.61},{"market":"US","date":"2026-03-05","symbol":"MGX","fiscalQuarterEnding":"2025/12","expectedEps":-0.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-11-11","symbol":"MGX","fiscalQuarterEnding":"2025/09","expectedEps":-0.6,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762837200000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2025-08-12","symbol":"MGX","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1763524800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MGX","date":"2026-08-21","current":-0.493976,"percent":1,"low":-9.442711,"twenty":-1.830276,"median":-0.948189,"eighty":-0.643141,"high":-0.485037,"avg":-1.545291,"sd":1.586695,"marketCap":45332526},"quantilePoints":[{"date":"2024-02-09","current":-9.442711,"twenty":-9.442711,"median":-9.442711,"eighty":-9.442711,"marketCap":600443120},{"date":"2024-02-16","current":-7.176461,"twenty":-7.229576,"median":-7.037771,"eighty":-6.65121,"marketCap":456336771},{"date":"2024-02-23","current":-6.910884,"twenty":-7.205969,"median":-6.940392,"eighty":-6.665374,"marketCap":439449308},{"date":"2024-03-01","current":-6.99941,"twenty":-7.181182,"median":-6.99941,"eighty":-6.772785,"marketCap":445078462},{"date":"2024-03-08","current":-7.082033,"twenty":-7.119804,"median":-7.020066,"eighty":-6.855408,"marketCap":450332340},{"date":"2024-03-15","current":-6.326616,"twenty":-7.086754,"median":-6.99941,"eighty":-6.735013,"marketCap":402296890},{"date":"2024-03-22","current":-6.674816,"twenty":-7.082033,"median":-6.93154,"eighty":-6.628783,"marketCap":424438230},{"date":"2024-03-28","current":-6.09746,"twenty":-7.082033,"median":-6.884327,"eighty":-6.536717,"marketCap":416182137},{"date":"2024-04-05","current":-5.539463,"twenty":-7.082033,"median":-6.751538,"eighty":-6.173335,"marketCap":378096021},{"date":"2024-04-12","current":-5.182609,"twenty":-7.082033,"median":-6.686619,"eighty":-5.880944,"marketCap":353738993},{"date":"2024-04-19","current":-4.25479,"twenty":-7.046623,"median":-6.65121,"eighty":-5.595462,"marketCap":290410720},{"date":"2024-04-26","current":-3.700295,"twenty":-7.019475,"median":-6.536126,"eighty":-5.173825,"marketCap":252563645},{"date":"2024-05-03","current":-3.387362,"twenty":-7.006492,"median":-6.326616,"eighty":-4.535881,"marketCap":231204405},{"date":"2024-05-10","current":-3.782646,"twenty":-6.981705,"median":-6.091054,"eighty":-4.026404,"marketCap":258184498},{"date":"2024-05-17","current":-3.394674,"twenty":-6.959278,"median":-5.940236,"eighty":-3.782646,"marketCap":262306457},{"date":"2024-05-24","current":-3.220091,"twenty":-6.927409,"median":-5.73985,"eighty":-3.687119,"marketCap":248816410},{"date":"2024-05-31","current":-3.09333,"twenty":-6.906163,"median":-5.586128,"eighty":-3.569632,"marketCap":239021602},{"date":"2024-06-07","current":-2.947876,"twenty":-6.887277,"median":-5.396721,"eighty":-3.453787,"marketCap":227782342},{"date":"2024-06-14","current":-2.690906,"twenty":-6.841244,"median":-5.039868,"eighty":-3.333555,"marketCap":207926315},{"date":"2024-06-21","current":-1.735756,"twenty":-6.789309,"median":-4.614389,"eighty":-3.224799,"marketCap":134121839},{"date":"2024-06-28","current":-1.97818,"twenty":-6.747997,"median":-4.446942,"eighty":-3.133088,"marketCap":152853940},{"date":"2024-07-05","current":-2.016967,"twenty":-6.733833,"median":-4.134009,"eighty":-3.103027,"marketCap":155851076},{"date":"2024-07-12","current":-2.492118,"twenty":-6.698423,"median":-3.856762,"eighty":-2.93333,"marketCap":192565993},{"date":"2024-07-19","current":-2.307876,"twenty":-6.674816,"median":-3.782646,"eighty":-2.511512,"marketCap":178329596},{"date":"2024-07-26","current":-2.16727,"twenty":-6.668915,"median":-3.70304,"eighty":-2.307876,"marketCap":167464978},{"date":"2024-08-02","current":-1.759998,"twenty":-6.65121,"median":-3.595984,"eighty":-2.244846,"marketCap":135995049},{"date":"2024-08-09","current":-1.396362,"twenty":-6.580389,"median":-3.549319,"eighty":-2.143028,"marketCap":107896898},{"date":"2024-08-16","current":-1.407311,"twenty":-6.539077,"median":-3.469713,"eighty":-2.050907,"marketCap":105549763},{"date":"2024-08-23","current":-1.60693,"twenty":-6.533176,"median":-3.394674,"eighty":-1.939392,"marketCap":120521360},{"date":"2024-08-30","current":-1.482168,"twenty":-6.421044,"median":-3.297683,"eighty":-1.842422,"marketCap":111164112},{"date":"2024-09-06","current":-1.357407,"twenty":-6.345502,"median":-3.243633,"eighty":-1.825409,"marketCap":101806863},{"date":"2024-09-13","current":-1.347426,"twenty":-6.244458,"median":-3.197572,"eighty":-1.757089,"marketCap":101058283},{"date":"2024-09-20","current":-1.222664,"twenty":-6.122752,"median":-3.122421,"eighty":-1.694059,"marketCap":91701035},{"date":"2024-09-27","current":-1.107883,"twenty":-6.08721,"median":-3.105451,"eighty":-1.618907,"marketCap":83092366},{"date":"2024-10-04","current":-1.008074,"twenty":-6.004384,"median":-3.09333,"eighty":-1.567006,"marketCap":75606567},{"date":"2024-10-11","current":-0.978131,"twenty":-5.949052,"median":-2.921209,"eighty":-1.486161,"marketCap":73360828},{"date":"2024-10-18","current":-0.978131,"twenty":-5.821651,"median":-2.545452,"eighty":-1.446237,"marketCap":73360828},{"date":"2024-10-25","current":-0.998093,"twenty":-5.765653,"median":-2.441209,"eighty":-1.397136,"marketCap":74857988},{"date":"2024-11-01","current":-1.052988,"twenty":-5.72832,"median":-2.307876,"eighty":-1.37138,"marketCap":78975177},{"date":"2024-11-08","current":-1.008074,"twenty":-5.650362,"median":-2.252118,"eighty":-1.339441,"marketCap":75606567},{"date":"2024-11-15","current":-0.920999,"twenty":-5.558129,"median":-2.215755,"eighty":-1.123853,"marketCap":68111528},{"date":"2024-11-22","current":-0.956422,"twenty":-5.429661,"median":-2.155149,"eighty":-1.07191,"marketCap":70731203},{"date":"2024-11-29","current":-1.047509,"twenty":-5.398917,"median":-2.118785,"eighty":-1.052988,"marketCap":77467508},{"date":"2024-12-06","current":-0.93618,"twenty":-5.268254,"median":-2.050907,"eighty":-1.047802,"marketCap":69234246},{"date":"2024-12-13","current":-1.63958,"twenty":-5.169433,"median":-2.046059,"eighty":-1.047998,"marketCap":121253491},{"date":"2024-12-20","current":-2.049475,"twenty":-5.015712,"median":-2.016967,"eighty":-1.050741,"marketCap":151566863},{"date":"2024-12-27","current":-1.892601,"twenty":-4.826854,"median":-2.016967,"eighty":-1.052737,"marketCap":139965449},{"date":"2025-01-03","current":-1.831876,"twenty":-4.658859,"median":-1.97818,"eighty":-1.052988,"marketCap":135474579},{"date":"2025-01-10","current":-1.583915,"twenty":-4.540273,"median":-1.953327,"eighty":-1.052988,"marketCap":117136860},{"date":"2025-01-17","current":-1.320773,"twenty":-4.529293,"median":-1.912844,"eighty":-1.057979,"marketCap":97676423},{"date":"2025-01-24","current":-1.502948,"twenty":-4.463412,"median":-1.894178,"eighty":-1.065797,"marketCap":111149033},{"date":"2025-01-31","current":-1.361256,"twenty":-4.29322,"median":-1.88121,"eighty":-1.07191,"marketCap":100670336},{"date":"2025-02-07","current":-1.254987,"twenty":-4.158165,"median":-1.837573,"eighty":-1.080935,"marketCap":92811314},{"date":"2025-02-14","current":-1.320773,"twenty":-3.918799,"median":-1.827877,"eighty":-1.098901,"marketCap":97676423},{"date":"2025-02-21","current":-1.194262,"twenty":-3.861703,"median":-1.815535,"eighty":-1.105887,"marketCap":88320444},{"date":"2025-02-28","current":-1.037388,"twenty":-3.856213,"median":-1.792877,"eighty":-1.092041,"marketCap":76719029},{"date":"2025-03-07","current":-1.047509,"twenty":-3.811194,"median":-1.759998,"eighty":-1.055983,"marketCap":77467508},{"date":"2025-03-14","current":-0.981724,"twenty":-3.782646,"median":-1.730908,"eighty":-1.047998,"marketCap":72602398},{"date":"2025-03-21","current":-0.785427,"twenty":-3.752999,"median":-1.696968,"eighty":-1.045708,"marketCap":61308894},{"date":"2025-03-28","current":-0.7088,"twenty":-3.716765,"median":-1.663388,"eighty":-1.037388,"marketCap":55327538},{"date":"2025-04-04","current":-0.675276,"twenty":-3.702491,"median":-1.63958,"eighty":-1.02271,"marketCap":52710695},{"date":"2025-04-11","current":-0.7088,"twenty":-3.680531,"median":-1.595422,"eighty":-1.017692,"marketCap":55327538},{"date":"2025-04-17","current":-0.727957,"twenty":-3.638807,"median":-1.578867,"eighty":-1.01007,"marketCap":56822877},{"date":"2025-04-25","current":-0.833319,"twenty":-3.595984,"median":-1.571997,"eighty":-0.998093,"marketCap":65047241},{"date":"2025-05-02","current":-0.771039,"twenty":-3.578416,"median":-1.555359,"eighty":-0.993103,"marketCap":60185789},{"date":"2025-05-09","current":-0.723149,"twenty":-3.549868,"median":-1.527083,"eighty":-0.982283,"marketCap":56447541},{"date":"2025-05-16","current":-0.796075,"twenty":-3.518791,"median":-1.502539,"eighty":-0.975137,"marketCap":62053281},{"date":"2025-05-23","current":-0.800871,"twenty":-3.474155,"median":-1.482168,"eighty":-0.958169,"marketCap":62427096},{"date":"2025-05-30","current":-0.853623,"twenty":-3.464404,"median":-1.462207,"eighty":-0.953828,"marketCap":66539061},{"date":"2025-06-06","current":-0.796075,"twenty":-3.43347,"median":-1.44474,"eighty":-0.94124,"marketCap":62053281},{"date":"2025-06-13","current":-0.695367,"twenty":-3.394674,"median":-1.425453,"eighty":-0.924035,"marketCap":54203167},{"date":"2025-06-20","current":-0.709754,"twenty":-3.394674,"median":-1.407311,"eighty":-0.885576,"marketCap":55324612},{"date":"2025-06-27","current":-0.762506,"twenty":-3.387362,"median":-1.40174,"eighty":-0.847687,"marketCap":59436577},{"date":"2025-07-03","current":-0.800871,"twenty":-3.315619,"median":-1.397004,"eighty":-0.834641,"marketCap":62427096},{"date":"2025-07-11","current":-1.059835,"twenty":-3.255007,"median":-1.396362,"eighty":-0.832584,"marketCap":82613103},{"date":"2025-07-18","current":-1.02147,"twenty":-3.243774,"median":-1.374408,"eighty":-0.834641,"marketCap":79622584},{"date":"2025-07-25","current":-1.203704,"twenty":-3.224799,"median":-1.367388,"eighty":-0.837481,"marketCap":93827552},{"date":"2025-08-01","current":-1.102996,"twenty":-3.215652,"median":-1.352416,"eighty":-0.842847,"marketCap":85977438},{"date":"2025-08-08","current":-0.920762,"twenty":-3.187391,"median":-1.341014,"eighty":-0.846956,"marketCap":71772470},{"date":"2025-08-15","current":-0.818579,"twenty":-3.176724,"median":-1.324118,"eighty":-0.83765,"marketCap":71312958},{"date":"2025-08-22","current":-0.797037,"twenty":-3.133088,"median":-1.312493,"eighty":-0.829422,"marketCap":69436301},{"date":"2025-08-29","current":-0.805654,"twenty":-3.114663,"median":-1.280289,"eighty":-0.825768,"marketCap":70186964},{"date":"2025-09-05","current":-0.766879,"twenty":-3.109815,"median":-1.247397,"eighty":-0.817251,"marketCap":66808982},{"date":"2025-09-12","current":-0.814271,"twenty":-3.104966,"median":-1.229685,"eighty":-0.814863,"marketCap":70937627},{"date":"2025-09-19","current":-0.921978,"twenty":-3.100118,"median":-1.207772,"eighty":-0.810262,"marketCap":80320911},{"date":"2025-09-26","current":-0.990911,"twenty":-3.095269,"median":-1.203704,"eighty":-0.812683,"marketCap":86326212},{"date":"2025-10-03","current":-1.072769,"twenty":-3.006058,"median":-1.17221,"eighty":-0.814228,"marketCap":93457508},{"date":"2025-10-10","current":-1.348501,"twenty":-2.939148,"median":-1.179081,"eighty":-0.814863,"marketCap":117478715},{"date":"2025-10-17","current":-1.434667,"twenty":-2.918785,"median":-1.204044,"eighty":-0.815258,"marketCap":124985342},{"date":"2025-10-24","current":-1.19771,"twenty":-2.778179,"median":-1.206102,"eighty":-0.815258,"marketCap":104342118},{"date":"2025-10-31","current":-1.051228,"twenty":-2.603634,"median":-1.204044,"eighty":-0.817251,"marketCap":91580851},{"date":"2025-11-07","current":-0.956445,"twenty":-2.525088,"median":-1.194262,"eighty":-0.818803,"marketCap":83323561},{"date":"2025-11-14","current":-0.719042,"twenty":-2.499876,"median":-1.17221,"eighty":-0.817251,"marketCap":63806331},{"date":"2025-11-21","current":-0.63891,"twenty":-2.451391,"median":-1.156357,"eighty":-0.814666,"marketCap":56695594},{"date":"2025-11-28","current":-0.740459,"twenty":-2.374785,"median":-1.141532,"eighty":-0.810062,"marketCap":65706814},{"date":"2025-12-05","current":-0.757383,"twenty":-2.311755,"median":-1.133086,"eighty":-0.806394,"marketCap":67208684},{"date":"2025-12-12","current":-0.736227,"twenty":-2.299149,"median":-1.122178,"eighty":-0.801346,"marketCap":65331346},{"date":"2025-12-19","current":-0.702378,"twenty":-2.262301,"median":-1.107883,"eighty":-0.801346,"marketCap":62327606},{"date":"2025-12-26","current":-0.736227,"twenty":-2.254543,"median":-1.102996,"eighty":-0.800871,"marketCap":65331346},{"date":"2026-01-02","current":-0.685453,"twenty":-2.250664,"median":-1.098114,"eighty":-0.799243,"marketCap":60825736},{"date":"2026-01-09","current":-0.748921,"twenty":-2.245816,"median":-1.08577,"eighty":-0.796075,"marketCap":66457749},{"date":"2026-01-16","current":-0.715071,"twenty":-2.221573,"median":-1.079018,"eighty":-0.791067,"marketCap":63454009},{"date":"2026-01-23","current":-0.740459,"twenty":-2.186664,"median":-1.072769,"eighty":-0.788421,"marketCap":65706814},{"date":"2026-01-30","current":-0.668528,"twenty":-2.16727,"median":-1.063793,"eighty":-0.781224,"marketCap":59323866},{"date":"2026-02-06","current":-0.596598,"twenty":-2.152725,"median":-1.052988,"eighty":-0.768967,"marketCap":52940918},{"date":"2026-02-13","current":-0.613523,"twenty":-2.1343,"median":-1.051899,"eighty":-0.76215,"marketCap":54442788},{"date":"2026-02-20","current":-0.643141,"twenty":-2.125218,"median":-1.047998,"eighty":-0.761469,"marketCap":57071061},{"date":"2026-02-27","current":-0.676991,"twenty":-2.116273,"median":-1.047509,"eighty":-0.754844,"marketCap":60074801},{"date":"2026-03-06","current":-0.681222,"twenty":-2.109756,"median":-1.044227,"eighty":-0.750541,"marketCap":60450269},{"date":"2026-03-13","current":-0.672193,"twenty":-2.10521,"median":-1.042611,"eighty":-0.74844,"marketCap":59064232},{"date":"2026-03-20","current":-0.629378,"twenty":-2.079998,"median":-1.037388,"eighty":-0.741197,"marketCap":55302179},{"date":"2026-03-27","current":-0.595126,"twenty":-2.050334,"median":-1.033026,"eighty":-0.740459,"marketCap":52292536},{"date":"2026-04-02","current":-0.573719,"twenty":-2.047822,"median":-1.027268,"eighty":-0.736489,"marketCap":50411510},{"date":"2026-04-10","current":-0.595126,"twenty":-2.040839,"median":-1.022207,"eighty":-0.732842,"marketCap":52292536},{"date":"2026-04-17","current":-0.616533,"twenty":-2.03733,"median":-1.021069,"eighty":-0.726784,"marketCap":54173563},{"date":"2026-04-24","current":-0.612252,"twenty":-2.02678,"median":-1.017601,"eighty":-0.720106,"marketCap":53797357},{"date":"2026-05-01","current":-0.590845,"twenty":-2.013348,"median":-1.013065,"eighty":-0.719094,"marketCap":51916331},{"date":"2026-05-08","current":-0.608399,"twenty":-1.994733,"median":-1.008109,"eighty":-0.714654,"marketCap":53458820},{"date":"2026-05-15","current":-0.591742,"twenty":-1.973209,"median":-1.007083,"eighty":-0.708991,"marketCap":50823526},{"date":"2026-05-22","current":-0.574209,"twenty":-1.953327,"median":-1.000589,"eighty":-0.706609,"marketCap":49317644},{"date":"2026-05-29","current":-0.613658,"twenty":-1.953327,"median":-0.998093,"eighty":-0.702378,"marketCap":52705879},{"date":"2026-06-05","current":-0.582975,"twenty":-1.939392,"median":-0.993103,"eighty":-0.700163,"marketCap":50070585},{"date":"2026-06-12","current":-0.547909,"twenty":-1.917904,"median":-0.992007,"eighty":-0.694414,"marketCap":47058821},{"date":"2026-06-18","current":-0.517226,"twenty":-1.909807,"median":-0.988847,"eighty":-0.690394,"marketCap":44423527},{"date":"2026-06-26","current":-0.521607,"twenty":-1.898161,"median":-0.986603,"eighty":-0.68537,"marketCap":44799761},{"date":"2026-07-02","current":-0.530373,"twenty":-1.893863,"median":-0.983122,"eighty":-0.681222,"marketCap":45552698},{"date":"2026-07-10","current":-0.55229,"twenty":-1.885766,"median":-0.979928,"eighty":-0.679384,"marketCap":47435041},{"date":"2026-07-17","current":-0.543523,"twenty":-1.88121,"median":-0.973678,"eighty":-0.676991,"marketCap":46682103},{"date":"2026-07-24","current":-0.534756,"twenty":-1.857937,"median":-0.969842,"eighty":-0.671511,"marketCap":45929166},{"date":"2026-07-31","current":-0.534756,"twenty":-1.842422,"median":-0.958169,"eighty":-0.662264,"marketCap":45929166},{"date":"2026-08-07","current":-0.543523,"twenty":-1.838543,"median":-0.956445,"eighty":-0.652989,"marketCap":46682103},{"date":"2026-08-14","current":-0.497163,"twenty":-1.832385,"median":-0.953755,"eighty":-0.648955,"marketCap":46465839},{"date":"2026-08-21","current":-0.485037,"twenty":-1.830276,"median":-0.948189,"eighty":-0.643141,"marketCap":45332526}],"updateTime":1787537300864},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MGX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634524237","title":"Metagenomi Q1 FY26 net loss narrows to $23.06 million; revenue drops to $1.25 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634524237","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634524237?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:13","pubTimestamp":1778530404,"startTime":"0","endTime":"0","summary":"Metagenomi Therapeutics posted a Q1 net loss of $23.06 million, narrowing from $25.04 million a year earlier; loss per share improved to $0.61 from $0.68.Collaboration revenue fell to $1.25 million from $4.13 million, while operating loss narrowed to $24.59 million from $27.82 million.R&D expense dropped to $19.3 million from $25.14 million; G&A expense edged down to $6.54 million from $6.81 million.Cash, cash equivalents, and available-for-sale marketable securities totaled $140.2 million as of March 31, with runway expected to support operations through 4Q 2027.MGX-001 for hemophilia A remained on track for regulatory submission including an IND in 4Q 2026, with first-in-human studies planned for 2027; Jian Irish said the program is supported by encouraging preclinical data and continued IND-enabling execution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL8yrnM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634316253","title":"Metagenomi Therapeutics Inc - Q1 Net Loss per Share $0.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2634316253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634316253?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:05","pubTimestamp":1778529904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUAC8LC1L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232216","title":"Press Release: Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:05","pubTimestamp":1778529900,"startTime":"0","endTime":"0","summary":"On track for regulatory submission of MGX-001 to advance global clinical program, including investigational new drug application  in 4Q 2026. Publication in Nature Structural & Molecular Biology highlights potential of MG119-28, a proprietary compact CRISPR nuclease with enhanced genome editing efficiency. $140.2 million in cash, cash equivalents, and available-for-sale marketable securities as of March 31, 2026, with runway anticipated to support operations through 4Q 2027. EMERYVILLE, Calif., May 11, 2026  -- Metagenomi Therapeutics, Inc.  , an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today reported financial results for the first quarter ended March 31, 2026, and provided business updates.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","MGX","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633115911","title":"Metagenomi Therapeutics Inc  expected to post a loss of 53 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633115911","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633115911?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:04","pubTimestamp":1778097851,"startTime":"0","endTime":"0","summary":"Metagenomi Therapeutics Inc  expected to post a loss of53cents a share - Earnings Preview Metagenomi Therapeutics Inc MGX.OQ MGX.O is expected to  show a rise in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J3BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630310776","title":"Metagenomi Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630310776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630310776?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:56","pubTimestamp":1777323398,"startTime":"0","endTime":"0","summary":"Metagenomi Therapeutics will hold its 2026 annual stockholders meeting virtually on June 9, 2026.Shareholders will vote to elect Juergen Eckhardt and Eric Bjerkholt as Class II directors with terms running to 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metagenomi Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLq5xBy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629089132","title":"MGX Resources Reports Lower March Quarter Iron Ore Sales; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629089132","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629089132?lang=en_us&edition=fundamental","pubTime":"2026-04-24 12:32","pubTimestamp":1777005178,"startTime":"0","endTime":"0","summary":"MGX Resources  reported March quarter iron ore sales of 390,000 wet metric tonnes, down from 715,000 wet metric tonnes a year earlier, according to a Friday filing with the Australian bourse.During the quarter, the company completed its acquisition of a 50% stake in the Central Tanami project joint venture in the Northern Territory for AU$50 million.MGX Resources said it is now working with JV partner Tanami Gold to determine the best path to a development decision and future production.Shares of MGX gained 3% in recent Friday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772377","title":"Macmahon Named Preferred Contractor for $38m Groundrush Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772377","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629772377?lang=en_us&edition=fundamental","pubTime":"2026-04-21 07:13","pubTimestamp":1776726802,"startTime":"0","endTime":"0","summary":"Macmahon Holdings Limited ( ($AU:MAH) ) has shared an update. The Central Tanami Project Joint Venture, owned equally by Tanami Gold NL and MGX Res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/macmahon-named-preferred-contractor-for-38m-groundrush-decline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/macmahon-named-preferred-contractor-for-38m-groundrush-decline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDX","NUGT","SGUmain","DUST","MGX","SGCmain","GLD","BK4139","159934","MGCmain","IAU","518880","GCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629377258","title":"Macmahon Named Preferred Contractor for $38m Groundrush Underground Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2629377258","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629377258?lang=en_us&edition=fundamental","pubTime":"2026-04-21 07:04","pubTimestamp":1776726241,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mount Gibson Iron Limited ( ($AU:MGX) ). Macmahon’s underground subsidiary has been selected as the preferred m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/macmahon-named-preferred-contractor-for-38m-groundrush-underground-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/macmahon-named-preferred-contractor-for-38m-groundrush-underground-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627629479","title":"Metagenomi reports compact CRISPR nuclease MG119-28 shows higher genome-editing efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2627629479","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627629479?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:01","pubTimestamp":1776337300,"startTime":"0","endTime":"0","summary":"Metagenomi published results in Nature Structural & Molecular Biology on April 16, 2026, detailing MG119-28, a compact Cas12f CRISPR nuclease with higher genome-editing efficiency than earlier compact nucleases.Study attributed performance gains to higher protein structural stability and a more stable guide RNA, supporting faster DNA cleavage.Researchers used structural and mechanistic findings to engineer MG119-28 for improved activity across multiple target genes.Metagenomi positioned MG119-28 as a step toward AAV-deliverable in vivo editing beyond liver targets, including potential neuromuscular disease applications.Company highlighted prior 2025 ASGCT mouse data showing 64% knockdown of Atxn2 protein from a single AAV delivering MG119-28 with a targeting guide.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5cxjFk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","NDAQ","MGX","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","SG9999014013.SGD","BK4139","SG9999014021.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627306292","title":"Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2627306292","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627306292?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:00","pubTimestamp":1776337200,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., April  16, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/16/3275169/0/en/Metagenomi-Therapeutics-Inc-Announces-Publication-in-Nature-Structural-Molecular-Biology-Highlighting-Proprietary-Compact-CRISPR-Nuclease-with-Enhanced-Genome-Editing-Efficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MGX","BK4556","CRSP","BK4611","LU1861559042.SGD","LU1861558580.USD","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627427037","title":"MGX Resources to Relocate Registered Office in West Perth","url":"https://stock-news.laohu8.com/highlight/detail?id=2627427037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627427037?lang=en_us&edition=fundamental","pubTime":"2026-04-15 06:28","pubTimestamp":1776205694,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mount Gibson Iron Limited ( ($AU:MGX) ). MGX Resources Limited has announced a change to its registered office ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mgx-resources-to-relocate-registered-office-in-west-perth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mgx-resources-to-relocate-registered-office-in-west-perth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164990788","title":"OpenAI Nearing $10 Billion Funding Round from MGX, Coatue, and Thrive Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1164990788","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164990788?lang=en_us&edition=fundamental","pubTime":"2026-03-25 03:50","pubTimestamp":1774381827,"startTime":"0","endTime":"0","summary":"According to informed sources, OpenAI is close to securing approximately $10 billion in new funding from investors, which would raise its valuation to $850 billion including the newly raised capital....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGX","THAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617658580","title":"Mangoceuticals announces patent filing for MGX-0024","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658580","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658580?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:10","pubTimestamp":1772831453,"startTime":"0","endTime":"0","summary":"Mangoceuticals (MGRX) “announced the filing of a Patent Cooperation Treaty (PCT) international application on February 26, 2026, to secure broad gl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mangoceuticals-announces-patent-filing-for-mgx-0024-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mangoceuticals-announces-patent-filing-for-mgx-0024-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4128","MGRX","BK4090","BK4139","PCT","MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630735","title":"Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630735","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630735?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:00","pubTimestamp":1772830800,"startTime":"0","endTime":"0","summary":"Dallas, TX, March  06, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure tel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/06/3251266/0/en/Mangoceuticals-Inc-Announces-PCT-Patent-Filing-for-MGX-0024-Antiviral-Technology-to-Include-Inhibiting-Respiratory-or-Orally-Acquired-Virus-Infection-in-Animals-or-Birds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","PCT","BK4128","BK4139","BK4090","MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617151570","title":"Chardan Capital Remains a Buy on Metagenomi, Inc. (MGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617151570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617151570?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:16","pubTimestamp":1772756208,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on Metagenomi, Inc., with a price target of $7.00. Liv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-metagenomi-inc-mgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chardan-capital-remains-a-buy-on-metagenomi-inc-mgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617576527","title":"Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576527","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576527?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:13","pubTimestamp":1772745236,"startTime":"0","endTime":"0","summary":"Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51083664/metagenomi-q4-eps-0-60-beats-0-62-estimate-sales-3-911m-miss-6-745m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617757681","title":"Metagenomi Therapeutics posts FY 2025 collaboration revenue of USD 25.2 million (-51.8%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617757681","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617757681?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:08","pubTimestamp":1772744899,"startTime":"0","endTime":"0","summary":"Metagenomi Therapeutics Inc. reported FY 2025 results, ending the year with USD 160.8 million in cash, cash equivalents and available-for-sale marketable securities as of December 31, 2025, and said its runway is anticipated to support operations through Q4 2027. For FY 2025, the company reported collaboration revenue of USD 25.2 million, R&D expenses of USD 94.4 million, G&A expenses of USD 26.8 million, loss from operations of USD 96.0 million, and net loss of USD 87.9 million . On business updates, Metagenomi said it completed a pre-IND meeting for MGX-001  following preclinical data showing curative FVIII activity in non-human primates, and remains on track for a global regulatory submission including an IND in Q4 2026, with clinical trials planned to start in 2027 subject to regulatory clearance. The company also reported in vivo proof-of-concept in non-human primates for antithrombin  deficiency, and highlighted preclinical data supporting APOC3 as a collaboration target with Ion","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLbJ2Ymp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","MGX","IONS","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","BK4588","LU2210149790.SGD","BK4585","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617750015","title":"Press Release: Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2617750015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617750015?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:05","pubTimestamp":1772744700,"startTime":"0","endTime":"0","summary":"Completed pre-IND meeting following MGX-001 preclinical data demonstrating curative FVIII activity in non-human primates  and remains on track for global regulatory submission including investigational new drug application  in 4Q 2026. Announced corporate name change to Metagenomi Therapeutics, Inc. to reflect Company's strategic evolution. $160.8 million in cash, cash equivalents and available-for-sale marketable securities as of December 31, 2025 with runway anticipated to support operations through 4Q 2027. \"2025 was a pivotal year for Metagenomi as we sharpened our strategic focus, advanced our core genome-editing technologies, and continued to demonstrate the breadth and durability of our technology across multiple therapeutic areas,\" said Jian Irish, Ph.D., M.B.A., President and Chief Executive Officer of the Company. \"Over the year, we made meaningful progress across our pipeline and collaborations, which reinforce the versatility of our signature technologies and our ability to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","MGX","LENZ","IND","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}]}}